Ultragenyx Pharmaceutical Inc. buy SVB Leerink LLC
Start price
30.12.25
/
50%
€17.00
Target price
30.12.26
€59.44
Performance (%)
39.82%
Price
08:32
?
Summary
This prediction is currently active. The BUY prediction by SVB_Leerink_LLC for Ultragenyx Pharmaceutical Inc. has seen massive gains of 39.82%. This prediction currently runs until 30.12.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -7.966% | -7.966% |
| iShares Core DAX® | 0,85 % | 0,39 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % |
| iShares S&P 500 | 0,06 % | 0,78 % |
Comments by SVB_Leerink_LLC for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Leerink Partners from $80.00 to $70.00. They now have an "outperform" rating on the stock.
Ratings data for RARE provided by MarketBeat